Suven Life Sciences Q4 Results

  • BSE: 530239
  • NSE: SUVEN
  • ISIN: INE495B01038
  • Sector: Biotechnology & Drugs
BSE
118.51.05 (0.89%)
Volume10.13 K
Updated: Mon 25 Nov, 2024 | 15:29:05
NSE
118.51.03 (0.88%)
Volume1.38 L
Updated: Mon 25 Nov, 2024 | 15:29:57
Today: 117.90
120.55
52-Wk: 75.95
169.00

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Suven Life Sciences Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 2.393.00-%2.61-%
    Selling/ General/ Admin Expenses Total 3.464.76-%3.93-%
    Depreciation/ Amortization 1.511.67-%1.67-%
    Other Operating Expenses Total 1.690.98-%1.29-%
    Total Operating Expense 34.1856.26-%35.80-%
    Operating Income -31.80-53.26-%-33.19-%
    Net Income Before Taxes -27.54-51.12-%-27.64-%
    Net Income -26.54-51.12-%-27.64-%
    Diluted Normalized EPS -1.22-2.67-%-1.60-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts